Conversely, we recently reported that in hypoxic KRAS mutant tumors, phospholipase C γ1 (PLCγ1) is suppressed, a phenomenon leading to impaired mitochondrial fitness and decreased FAO, which boosts tumor growth [29]. Here, KRAS is linked to neoplasm.